Ningxia Zhongke Biotechnology Co., Ltd.
Shanghai Stock Exchange 600165.SS
Ningxia Zhongke Biotechnology Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 5.99
Ningxia Zhongke Biotechnology Co., Ltd. Price to Sales Ratio (P/S) is 5.99 on January 14, 2025, a -22.01% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
-
Ningxia Zhongke Biotechnology Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 10.38 on March 28, 2024, which is 73.29% above the current Price to Sales Ratio (P/S).
-
Ningxia Zhongke Biotechnology Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 2.98 on June 13, 2024, which is -50.15% below the current Price to Sales Ratio (P/S).
-
Ningxia Zhongke Biotechnology Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 4.98.
Key data
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
Market news
Loading...
Shanghai Stock Exchange: 600165.SS
| CEO | Mr. Rui Chen |
| IPO Date | May 29, 1998 |
| Location | China |
| Headquarters | Hengtai Business Building |
| Employees | 731 |
| Sector | Materials |
| Industries | |
Description
Ningxia Zhongke Biotechnology Co., Ltd. engages in the manufacturing chemical raw materials and chemical products. It offers coal-based activated carbon and lauric acid products, as well as manufactures bio-based chemical fibers. The company was founded in 1958 and is based in Yinchuan, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email